A phase I clinical and pharmacokinetic study of the multi-drug resistance protein-1 (MRP-1) inhibitor sulindac, in combination with epirubicin in patients with advanced cancer.

File Type:

PDF

Item Type:

Journal Article

Date:

2007

Author:

O'DRISCOLL, LORRAINE

Access:

openAccess

Citation:

O'Connor R, O'Leary M, Ballot J, Collins CD, Kinsella P, Mager DE, Arnold RD, O'Driscoll L, Larkin A, Kennedy S, Fennelly D, Clynes M, Crown J., A phase I clinical and pharmacokinetic study of the multi-drug resistance protein-1 (MRP-1) inhibitor sulindac, in combination with epirubicin in patients with advanced cancer., Cancer Chemother Pharmacol., 59, 1, 2007, 79 - 87

Download Item:

  (O'Connor et al. 2007... Phase I clinical trial.pdf)  291.3Kb

URI:

http://hdl.handle.net/2262/78969

Author's Homepage:

http://people.tcd.ie/lodrisc

Description:

PUBLISHED

Author: O'DRISCOLL, LORRAINE

Type of material:

Journal Article

URI:

http://hdl.handle.net/2262/78969

Collections

• Pharmacy and Pharmaceutical Sciences (Scholarly Publications)
• RSS Feeds

Series/Report no:

Cancer Chemother Pharmacol.
59
1

Availability:

Full text available

DOI:

10.1007/s00280-006-0240-7

Metadata

Show full item record